A bill to prioritize funding for the National Institutes of Health to discover treatments and cures, to maintain global leadership in medical innovation, and to restore the purchasing power the NIH had after the historic doubling campaign that ended in fiscal year 2003.
The bill’s titles are written by its sponsor.
Sponsor. Senator for Maryland. Democrat.
Last Updated: Jan 29, 2015
Length: 7 pages
Jan 29, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on January 29, 2015, in a previous session of Congress, but was not enacted.
Jan 29, 2015
S. 318 (114th) was a bill in the United States Congress.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2017). S. 318 — 114th Congress: Accelerating Biomedical Research Act. Retrieved from https://www.govtrack.us/congress/bills/114/s318
“S. 318 — 114th Congress: Accelerating Biomedical Research Act.” www.GovTrack.us. 2015. December 12, 2017 <https://www.govtrack.us/congress/bills/114/s318>
|title=S. 318 (114th)
|accessdate=December 12, 2017
|author=114th Congress (2015)
|date=January 29, 2015
|quote=Accelerating Biomedical Research Act